191 related articles for article (PubMed ID: 33864956)
21. Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma.
Li X; Liu M; Shi Q; Fang Y; Fu D; Shen ZX; Yi H; Wang L; Zhao W
Hematol Oncol; 2023 Apr; 41(2):230-238. PubMed ID: 35304777
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
23. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
[TBL] [Abstract][Full Text] [Related]
24. Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.
García M; Bellosillo B; Sánchez-González B; García-Payarols F; Seoane A; Ferrer AM; Gimeno E; Barranco LE; Torner A; Solé F; Besses C; Serrano S; Salar A
PLoS One; 2012; 7(12):e51681. PubMed ID: 23284739
[TBL] [Abstract][Full Text] [Related]
25. The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL).
Dehghani M; Shokrgozar N; Ramzi M; Kalani M; Golmoghaddam H; Arandi N
Cancer Immunol Immunother; 2021 Oct; 70(10):2961-2969. PubMed ID: 33721055
[TBL] [Abstract][Full Text] [Related]
26. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
[TBL] [Abstract][Full Text] [Related]
27. Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma.
Chang C; Chen YP; Medeiros LJ; Chen TY; Chang KC
Leuk Lymphoma; 2021 Jan; 62(1):76-85. PubMed ID: 32962457
[TBL] [Abstract][Full Text] [Related]
28. Quercetin protects mouse liver against triptolide-induced hepatic injury by restoring Th17/Treg balance through Tim-3 and TLR4-MyD88-NF-κB pathway.
Wei CB; Tao K; Jiang R; Zhou LD; Zhang QH; Yuan CS
Int Immunopharmacol; 2017 Dec; 53():73-82. PubMed ID: 29040945
[TBL] [Abstract][Full Text] [Related]
29. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
[TBL] [Abstract][Full Text] [Related]
30. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
[TBL] [Abstract][Full Text] [Related]
31. Diffuse large B-cell lymphoma: the significance of CD8
Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
[TBL] [Abstract][Full Text] [Related]
32. The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone.
Rajnai H; Heyning FH; Koens L; Sebestyén A; Andrikovics H; Hogendoorn PC; Matolcsy A; Szepesi Á
Virchows Arch; 2014 Feb; 464(2):229-39. PubMed ID: 24306958
[TBL] [Abstract][Full Text] [Related]
33. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
34. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
35. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
36. CD27
Zhu G; Liu Y; Zhang W; Huang Y; Li K
Immunol Res; 2018 Apr; 66(2):281-287. PubMed ID: 29392553
[TBL] [Abstract][Full Text] [Related]
37. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
38. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
39. Tim-3 expression defines regulatory T cells in human tumors.
Yan J; Zhang Y; Zhang JP; Liang J; Li L; Zheng L
PLoS One; 2013; 8(3):e58006. PubMed ID: 23526963
[TBL] [Abstract][Full Text] [Related]
40. [Expression of PD-1, TIM-3, LAG-3 and BTLA in diffuse large B-cell lymphoma and its effect on prognosis].
Liu XY; Yuan XL; Ma RJ; Xu H; Yang SW; Nie L; Zhang L; Hu AX; Li Z; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2846-2853. PubMed ID: 32988145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
